Crystagen

Also known as: Immune System Bioregulator, Thymus-like Bioregulator

A bioregulator peptide for immune system support and thymus function.

Overview

Crystagen is a synthetic tripeptide from the Khavinson bioregulator family designed to support immune system function. It may help maintain healthy immune responses and support thymus function, particularly during aging when thymus involution occurs.

Mechanism of Action

Gene regulatory effects on immune cells. Proposed to normalize T-cell function and cytokine balance. May support thymic output and immune competence.

Pharmacokinetics

Small peptide allows oral/sublingual administration. Effects on lymphoid tissue.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Immune Support

Dose

10-20 mg

Frequency

1-2x daily

Duration

10-30 days

2-3 courses per year

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Immune enhancement

Synergy: Comprehensive immune system support

Research Areas

Immune FunctionImmunosenescenceThymus SupportInfection PreventionAutoimmunityCancer Immunity

Key Research Findings

  • 1Improved immune parameters in elderly
  • 2Enhanced T-cell function
  • 3Reduced infection frequency
  • 4Gene expression modulation in immune cells

Side Effects & Contraindications

Reported Side Effects

  • Generally well-tolerated

Contraindications

  • Autoimmune conditions (use cautiously)

Safety Considerations

Generally well-tolerated. Limited Western clinical data. Consider in context of immune status.

Storage Requirements

Store at room temperature

Scientific References

Quick Reference

Sequence
Glu-Asp-Pro
Molecular Weight
~359 g/mol
Half-Life
Short
Bioavailability
Oral/sublingual
Research Stage
clinical phase 2
Administration
Oral or sublingual